Results 141 to 150 of about 51,762 (264)

Reversible cerebral vasoconstriction syndrome: A narrative review

Headache: The Journal of Head and Face Pain, Volume 66, Issue 5, Page 1162-1180, May 2026.
Abstract Objectives/Background This review summarizes current insights into Reversible cerebral vasoconstriction syndrome (RCVS) diagnosis, management, and outcomes. RCVS is a cerebrovascular disorder characterized by recurrent thunderclap headaches and transient segmental vasoconstriction of cerebral arteries, typically resolving within 3 months ...
Ícaro Araújo de Sousa, Abner da Silva Machado, Arthur de Oliveira Veras, Thiago Oscar Goulart, Sarah Galassi Tatsuta, Trajano Aguiar Pires Gonçalves, Eva Rocha, Octávio Marques Pontes‐Neto   +7 more
wiley   +1 more source

Association of glucagon‐like peptide‐1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes

Journal of Diabetes Investigation, Volume 17, Issue 5, Page 766-780, May 2026.
This TriNetX (US, 2016–2023) study compared clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes treated with GLP‐1 receptor agonists vs DPP4 inhibitors. ABSTRACT Objectives To evaluate whether glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are associated with improved survival and renal outcomes in patients with ...
Yu‐Ting Yu, Ying Chun Lee, Yu‐Wei Fang, Wen‐Hui Hsieh, Ming‐Hsien Tsai   +4 more
wiley   +1 more source

Low‐Dose vs. Standard Care Iv Human Albumin During Large‐Volume Paracentesis in Patients With Liver Cirrhosis: A Systematic Review

Liver International, Volume 46, Issue 5, May 2026.
ABSTRACT Cirrhosis is a global health concern, with ascites being the most prevalent decompensating event. Intravenous (IV) human albumin (HA) is administered during large‐volume paracentesis (LVP) to prevent complications. The standard (6–8 g HA/L ascites) is empirically chosen, potentially leading to overtreatment and added costs.
Kimberly K. I. M. Bot, Roebi Heus, Joost P. H. Drenth, Marten A. Lantinga   +3 more
wiley   +1 more source

Safety and efficacy of nebulized nitroglycerin as a vaso-reactive agent in pulmonary arterial hypertension

The Egyptian Journal of Bronchology
Background Pulmonary arterial hypertension (PAH) is a progressive vascular disease characterized by elevation in both mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR), ending by right ventricular hypertrophy then failure ...
Ahmed Mostafa Ahmed, Mohsen Elshafey, Amany Ragab Elsaid, Mohamed. M. Elgamal   +3 more
doaj   +1 more source

Design, Synthesis, and Evaluation of New Polyhydroxylated Bis‐Chalcones as Potential COX‐2 Selective Inhibitors

ChemMedChem, Volume 21, Issue 8, 28 April 2026.
Novel polyhydroxylated bis‐chalcones were successfully synthesized and demonstrated COX‐2 selective inhibition. The most potent and selective inhibitor exhibited a mixed‐type inhibition mechanism with COX‐2. Its additional bulk preferentially blocked the access to the active pocket of COX‐1 rather than COX‐2. Selective inhibition of COX‐2 is considered
Rui Pereira, Alberto N. Araújo, Daniela Ribeiro, Ismael Rufino, Nuno Martinho, Rita C. Guedes, Vera L. M. Silva, Eduarda Fernandes   +7 more
wiley   +1 more source

The Effectiveness of Intravenous Magnesium Sulfate for Deliberate Hypotension in Rhinoplasty

Archives of Anesthesia and Critical Care, 2015
Background: Deliberate hypotension is a strategy that reduces intraoperative bleeding and increases the speed of surgery in otolaryngology procedures. Magnesium (Mg) sulfate is a vasodilator agent that reduces intraoperative hypnotic requirements and in ...
Seyed Mohammad Mireskandari, Kasra Karvandian, Afshin Jafarzadeh, Jalil Makarem, Shahram Samadi, Asghar Hajipour, Negar Eftekhar, Sanaz Shabani, Mohammad Fatehi, Jayran Zebardast   +9 more
doaj  

Regadenoson in the detection of coronary artery disease

Vascular Health and Risk Management, 2008
Christiane Buhr1, Mario Gössl2, Raimund Erbel1, Holger Eggebrecht11Department of Cardiology, West-German Heart Center Essen, University of Duisburg-Essen, Essen, Germany; 2Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905,
Christiane Buhr, Mario Gössl, Raimund Erbel, Holger Eggebrecht   +3 more
doaj  

Vasodilator stress agents for myocardial perfusion imaging [PDF]

Journal of Nuclear Cardiology, 2017
Rayan, Saab, Fadi G, Hage
openaire   +2 more sources

Utilization patterns and determinants of guideline-recommended therapies for acute heart failure in Denmark. [PDF]

Eur Heart J Acute Cardiovasc Care
Mkoma GF, Hviid A, Pasternak B, Svanström H.   +3 more
europepmc   +1 more source